Research Topics
Genomes and GenesSpecies | P GuilfordSummaryAffiliation: University of Otago Country: New Zealand Publications
| Collaborators
|
Detail Information
Publications
Increased levels of active c-Src distinguish invasive from in situ lobular lesionsDonghui Zou
Cancer Genetics Laboratory, Biochemistry Department, University of Otago, 710 Cumberland St, Dunedin 9054, Aotearoa New Zealand
Breast Cancer Res 11:R45. 2009..Here, we investigated whether c-Src kinase, an established inducer of invasive states, contributes to the progression from ALH/LCIS to ILC...
A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: a case control study in an Italian populationSoroush Nasri
Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin 9054, Aotearoa New Zealand
BMC Cancer 8:138. 2008..Recently, a new regulatory region essential for CDH1 transcription has been identified in CDH1 intron 2...
E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancerP J Guilford
Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand
Hum Mutat 14:249-55. 1999..These results demonstrate that germline mutation of the E-cadherin gene is a common cause of hereditary diffuse gastric cancer and suggest a role for these mutations in the incidence of breast cancer...
The inherited susceptibility to cancerP Guilford
Biochemistry Department, University of Otago, Dunedin, New Zealand
Cell Mol Life Sci 57:589-603. 2000..All the recessively inherited genes have been implicated in the maintenance of genome stability. This review summarises our current understanding of the functions of the major cancer susceptibility genes...
E-cadherin germline mutations in familial gastric cancerP Guilford
Cancer Genetics Laboratory, Biochemistry Department, University of Otago, Dunedin, Aotearoa New Zealand
Nature 392:402-5. 1998..These results describe, to our knowledge for the first time, a molecular basis for familial gastric cancer, and confirm the important role of E-cadherin mutations in cancer...
Identification of seven novel germline mutations in the human E-cadherin (CDH1) geneH More
Cancer Genetics Laboratory, University of Otago, Dunedin, Aotearoa, New Zealand
Hum Mutat 28:203. 2007..Together with the occurrence of extra-gastric tumours such as lobular breast and colorectal cancer, these findings further extend the types of CDH1 mutations and the spectrum of tumours associated with HDGC...
Hereditary diffuse gastric cancerA Dunbier
Department of Biochemistry, University of Otago, Dunedin, New Zealand
Adv Cancer Res 83:55-65. 2001..Here, we review the identified families, mutations, and proposed mechanisms by which E-cadherin loss promotes tumorigenesis...
E-cadherin downregulation in cancer: fuel on the fire?P Guilford
Cancer Genetics Laboratory, Biochemistry Dept, University of Otago, PO Box 56, Dunedin, New Zealand
Mol Med Today 5:172-7. 1999..Germline mutation of the E-cadherin gene predisposes to diffuse, poorly differentiated gastric cancer, and its downregulation in sporadic tumours is associated with poor clinical prognosis...
Adrenomedullin interacts with VEGF in endometrial cancer and has varied modulation in tumours of different gradesJ J Evans
Department of Obstetrics and Gynaecology, University of Otago, Christchurch, Christchurch, New Zealand
Gynecol Oncol 125:214-9. 2012..The study investigated characteristics of adrenomedullin in endometrial cancer to assist in identifying targets for developing treatments...
Single nucleotide polymorphisms (SNPs) at CDH1 promoter region in familial gastric cancerA Ramos-de la Medina
Department of Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Rev Esp Enferm Dig 98:36-41. 2006..Germline mutations in the E-cadherin gene (CHD1) have been described that result in the development of diffuse hereditary gastric cancer in young patients...
The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practiceF Graziano
Medical Oncology Unit, Hospital of Urbino, Italy
Ann Oncol 14:1705-13. 2003..CDH1 promoter hypermethylation seems a key event in the carcinogenetic process of poorly differentiated, diffuse gastric cancer and it deserves further investigation as a new target for anticancer therapies with demethylating agents...
Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zoneA Charlton
Department of Pathology, Middlemore Hospital, Otahuhu, Auckland, New Zealand
Gut 53:814-20. 2004..Targeting the transitional zone would maximise the likelihood of finding foci in macroscopically normal gastrectomies, and particular attention should be paid to this area during endoscopy...
Somatic mutations of KIT in familial testicular germ cell tumoursE A Rapley
Section of Cancer Genetics, Institute of Cancer Research, Brookes Lawley Building, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK
Br J Cancer 90:2397-401. 2004..They also lend support to the hypothesis that KIT mutations primarily take place during embryogenesis such that primordial germ cells with KIT mutations are distributed to both testes...
Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?D Shaw
Tauranga Hospital, Private Bag 12 024, Tauranga, New Zealand
Gut 54:461-8. 2005..The results of annual chromoendoscopic surveillance using the methylene blue/congo red technique in 33 mutation carriers over a five year period are described...
A gene responsible for a dominant form of neurosensory non-syndromic deafness maps to the NSRD1 recessive deafness gene intervalH Chaib
Unite de Genetique Moleculaire Humaine, URA CNRS 1445, Institut Pasteur, Paris, France
Hum Mol Genet 3:2219-22. 1994..A multipoint analysis gave a maximum lod score of 4.66 with a most likely location close to locus D13S175. This suggests that different mutations in NSRD1 may cause both dominant and recessive neurosensory deafness...
A human gene responsible for neurosensory, non-syndromic recessive deafness is a candidate homologue of the mouse sh-1 geneP Guilford
Unite de Genetique Moleculaire Humaine, Institut Pasteur, Paris, France
Hum Mol Genet 3:989-93. 1994..The murine homologue of OMP is tightly linked to the autosomal recessive deafness gene sh-1. These results, and clinical data, suggest that NSRD2 is the human homologue of the mouse sh-1 gene...
A non-syndrome form of neurosensory, recessive deafness maps to the pericentromeric region of chromosome 13qP Guilford
Unite de Genetique Moleculaire Humaine, URA CNRS 1445, Institut Pasteur, Paris, France
Nat Genet 6:24-8. 1994..These data map this neurosensory deafness gene to the same region of chromosome 13q as the gene for severe, childhood autosomal recessive muscular dystrophy...
A YAC contig and an EST map in the pericentromeric region of chromosome 13 surrounding the loci for neurosensory nonsyndromic deafness (DFNB1 and DFNA3) and limb-girdle muscular dystrophy type 2C (LGMD2C)P Guilford
Unite de Genetique Moleculaire Humaine, URA CNRS 1968, Institut Pasteur, Paris, France
Genomics 29:163-9. 1995..YAC screening of a cDNA library derived from mouse cochlea allowed us to identify an alpha-tubulin gene (TUBA2) that was subsequently precisely mapped within the candidate region...
Defective myosin VIIA gene responsible for Usher syndrome type 1BD Weil
Unité de Génétique Moléculaire Humaine URA CNRS 1968, Institut Pasteur, Paris, France
Nature 374:60-1. 1995..Thus USH1B appears as a primary cytoskeletal protein defect. These results implicate the genes encoding other unconventional myosins and their interacting proteins as candidates for other genetic forms of Usher syndrome...
